10/2/2013 7:33:47 AM
Cerecor Inc., a biopharmaceutical company developing neuroscience drugs that make a difference in underserved patient segments of common diseases, today announced that Blake Paterson, MD, CEO and Co-Founder, will present a corporate overview, highlighting CERC-301, an oral rapid-acting antidepressant in clinical development for treatment-resistant depression, and its COMT inhibitor platform for the treatment of the cognitive impairment observed in many different conditions at the 12th Annual BIO Investor Forum in San Francisco, CA. The presentation will take place on Wednesday, October 9, 2013, at 2pm PT.
Help employers find you! Check out all the jobs and post your resume.
comments powered by